NCT02743234View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

August 31, 2019

Conditions
Clostridium Difficile Infection
Interventions
OTHER

Fecal microbiota transplantation

FMT follows 4-10 days of vancomycin 125 mg x 4 daily

DRUG

Fidaxomicin

Fidaxomicin 200 mg x 2 daily for 10 days

DRUG

Vancomycin

Vancomycin 125 mg x 4 daily for 10 days

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus C

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02743234 - Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection | Biotech Hunter | Biotech Hunter